Yunnan Baiyao Group Co.,Ltd

Shenzhen Stock Exchange 000538.SZ

Yunnan Baiyao Group Co.,Ltd EBITDA Margin for the year ending December 31, 2023: 11.82%

Yunnan Baiyao Group Co.,Ltd EBITDA Margin is 11.82% for the year ending December 31, 2023, a 10.59% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Yunnan Baiyao Group Co.,Ltd EBITDA Margin for the year ending December 31, 2022 was 10.68%, a -1.01% change year over year.
Yunnan Baiyao Group Co.,Ltd EBITDA Margin for the year ending December 31, 2021 was 10.79%, a -50.66% change year over year.
Yunnan Baiyao Group Co.,Ltd EBITDA Margin for the year ending December 31, 2020 was 21.87%, a 27.55% change year over year.
Yunnan Baiyao Group Co.,Ltd EBITDA Margin for the year ending December 31, 2019 was 17.15%, a 9.73% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Shenzhen Stock Exchange: 000538.SZ

Yunnan Baiyao Group Co.,Ltd

CEO	Mr. Ming Dong
IPO Date	Dec. 15, 1993
Location	China
Headquarters	No. 3686, Yunnan Baiyao Street
Employees	8,834
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China and internationally. It provides health products, drugs, medical instruments, Chinese medicine resources, and tea. The company offers its products under the Yunnan Baiyao, Yunfeng, Tong Qiaoqiao, Yunjian, Life, Jinkoujian, Langjian, Yangyuanqing, Caizhiji, Baiyao Health, Leopard Seven, Qiancaotang, Qiancao Meizi, and Tianzihong brand names. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.

Key trends

Past 5 years